Key result
Vigorous pulmonary therapy was associated with 0% mortality compared to 40.9% (9 deaths) in a retrospective cohort of patients with acute traumatic quadriplegia.
Why the study?
Does vigorous pulmonary therapy designed to prevent or reverse secretion retention improve survival and reduce pulmonary complications in patients with acute traumatic quadriplegia?
Cohort (n=44)
Does vigorous pulmonary therapy designed to prevent or reverse secretion retention improve survival and reduce pulmonary complications in patients with acute traumatic quadriplegia?
Absolute Event Rate: 0% vs 40.9%
Vigorous pulmonary therapy designed to prevent secretion retention significantly improves survival and reduces pulmonary complications in patients with acute traumatic quadriplegia.
May support vigorous pulmonary therapy in acute traumatic quadriplegia; hypothesis-generating and requires randomized confirmation before practice change.
A prospective study of the pulmonary complications occurring in 22 consecutive patients admitted to hospital within 24 hours after acute traumatic quadriplegia was compared with the findings of a retrospective survey of 22 comparable patients. Patients in the prospective group received therapy designed to prevent or reverse secretion retention. All patients in this group survived. In the retrospective group there were nine deaths; pulmonary complications and the need for tracheal intubation and mechanical ventilation were three times more frequent. Serial pulmonary function testing in the prospective group demonstrated a greater compromise of expiration than inspiration and progressive improvement in diaphragm function with time. It is concluded that vigorous pulmonary therapy in the prospective group was associated with increased survival, a decreased incidence of pulmonary complications, and a decreased need for ventilatory support.
No takes yet. Share an insight, caveat, or question.
McMichan Jc (1980) conducted a cohort in Acute traumatic quadriplegia (n=44). Vigorous pulmonary therapy (designed to prevent or reverse secretion retention) vs. Retrospective historical control was evaluated on Mortality. Vigorous pulmonary therapy was associated with 0% mortality compared to 40.9% (9 deaths) in a retrospective cohort of patients with acute traumatic quadriplegia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: